Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer
Nabholtz J, Murawsky M, Alaki M, Aapro M, Drbal J, Trillet-Lenoir V, Rosso R, Rapoport B, Vandenberg T, Douma J, Deschênes L, Melnychuk D, Bezwoda W, Thürlimann B, Riva A. Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer. Oncology (Williston Park, N.Y.) 1997; 11:25-30.
Aug 1, 1997
Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer
Aug 1, 1997
Oncology (Williston Park, N.Y.) 1997; 11:25-30
Nabholtz J M, Murawsky M, Alaki M, Aapro M S, Drbal J, Trillet-Lenoir V, Rosso R, Rapoport B, Vandenberg T A, Douma J, Deschênes L, Melnychuk D, Bezwoda W R, Thürlimann Beat, Riva A
more
